Skip to content

Impact of the “DNT 30-Minute Initiative” on DNT and clinical outcomes of intravenous thrombolysis in patients with AIS

Impact of the “DNT 30-Minute Initiative” on DNT and clinical outcomes of intravenous thrombolysis in patients with AIS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103116
Enrollment
Unknown
Registered
2025-05-26
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Control group:none
DNT 30-minute group:Stroke green channel process and related measures targeting 30 minutes of DNT

Sponsors

Chengdu Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Symptoms of neurological deficit due to ischemic stroke; 3. 0-4.5 h of symptom onset; 2. Age >= 18 years; 3. Signed informed consent by patient or family member;

Exclusion criteria

Exclusion criteria: 1. Intracranial hemorrhage (including parenchymal hemorrhage, intraventricular hemorrhage, subarachnoid hemorrhage, subdural/extracranial hematoma, etc.); 2. History of previous intracranial hemorrhage; 3. History of severe head trauma or stroke within the last 3 months; 4. Intracranial tumor, giant intracranial aneurysm; 5. Recent (3 months) intracranial or intraspinal surgery; 6. Major surgery in the last 2 weeks; 7. Gastrointestinal or urinary bleeding in the last 3 weeks; 8. Active visceral hemorrhage; 9. Aortic arch entrapment; 10. Arterial puncture at a site not easily compressible for hemostasis within the last 1 week; 11. Elevated blood pressure: systolic blood pressure >= 180 mmHg or diastolic blood pressure >= 100 mmHg; 12. Acute hemorrhagic tendency, including platelet count 1.7 or PT >15 s; 15. Use of thrombin inhibitors or factor Xa inhibitors within 48 h, or abnormalities in various laboratory tests (e.g., APTT, INR, platelet count, ECT, TT, or factor Xa activity assay); 16. Blood glucose 22.22 mmol/L; 17. Large infarcts (infarct size >1/3 of the middle cerebral artery blood-supplying area) on CT or MRI of the head;

Design outcomes

Primary

MeasureTime frame
Proportion of DNT <=30 minutes pre- and post-intervention;Clinical outcomes before and after the intervention;Median DNT before and after intervention;

Countries

China

Contacts

Public ContactWang Jian

Chengdu Second People's Hospital

42523748@qq.com+86 28 65108275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026